Joshua Pinto Insider Profile
4 Followers
Joshua Pinto, President & CEO, Director at Neumora Therapeutics, Inc., holds 209.95K shares in Neumora Therapeutics, Inc. (Ticker: NMRA), holds 0.00 shares in Metsera, Inc. (Ticker: MTSR). Most recently, Joshua Pinto Sold ― shares of Neumora Therapeutics, Inc. on Feb 19, 2026 for an estimated value of $21.06K.
Joshua Pinto's Trading History
| NMRANeumora Therapeutics, Inc. | Feb 19, 2026 | President & CEO, Director | Informative Sell | 21.06K | $89.86K | |
| MTSRMetsera, Inc. | Nov 13, 2025 | ― | Uninformative Sell | ― | $0.00 |
You May Also Like
Joshua Pinto insider profile FAQ
What stocks does Joshua Pinto hold?
Joshua Pinto holds: NMRA, MTSR stocks.
What was Joshua Pinto’s latest transaction?
Joshua Pinto’s latest transaction was an Informative Sell of $21.06K.
What is Joshua Pinto's role in Neumora Therapeutics, Inc.?
Joshua Pinto's role in Neumora Therapeutics, Inc. is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
